Used directly on the surface of your skin
TOPICAL CREAMS
© Janssen Biotech, Inc. 2022 09/22 cp-332748v1
4 Types of Treatments
There are 4 groups of medications used to treat plaque psoriasis.
LIGHT THERAPY
Your skin, or just the psoriatic plaque, is exposed to ultraviolet light
(UVB rays or Psoralen plus UVA rays [PUVA])
BIOLOGICS
Injectable treatments that target a possible cause of your psoriasis
ORAL SYSTEMIC THERAPIES
Pills that work either throughout the body or on a specific target
FIRST 52 WEEKS OF THERAPY
This is dosing information for adults. Find STELARA® dosing information for adolescents.
See how the dosing for STELARA® compares to an oral systemic therapy for the treatment of plaque psoriasis during the first 52 weeks of therapy.
OTEZLA®* (apremilast)
Twice daily after starter dose (dosing milligrams vary during first five days of treatment). Blocks phosphodiesterase 4 (PDE4) enzyme involved in inflammatory and immune responses.
OTEZLA® is indicated for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
While these factors are important, there are additional considerations for selecting treatment. Please talk to your doctor about treatment options and what might be right for you.
This presentation is not intended to compare the safety and effectiveness of these treatments. Please refer to each product’s full Prescribing Information for recommended dosing and administration.
STELARA® is a 45 mg or 90 mg injection given under the skin as directed by your doctor at weeks 0, 4, and every 12 weeks thereafter. It is administered by a healthcare provider or self-injected only after proper training. If your doctor decides that you or a caregiver may give your injections at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject yourself until you or your caregiver has been properly trained by a healthcare provider.
*Indicated trademarks are registered trademarks of their respective owners.
^Based on the recommended 300-mg dose. 150 mg may be acceptable for some patients.
No footer links content fetched